Letter: should we abandon FIB-4 to characterise non-invasively patients with NAFLD?

被引：1
|
作者：
Pugliese, Nicola [1 ]
Franchellucci, Gianluca [1 ,2 ]
Vigano, Mauro [3 ]
机构：
[1] IRCCS Humanitas Res Hosp, Dept Gastroenterol, Div Internal Med & Hepatol, Rozzano, MI, Italy
[2] Humanitas Univ, Dept Biomed Sci, Pieve Emanuele, MI, Italy
[3] ASST Papa Giovanni XXIII, Gastroenterol Hepatol & Transplantat Unit, Bergamo, Italy
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2023年 / 57卷 / 08期
关键词：
D O I：
10.1111/apt.17422
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LINKED CONTENT This article is linked to Younossi et al papers. To view these articles, visit and
引用
收藏
页码：920 / 921
页数：2
相关论文
共 50 条
  • [1] Letter: should we abandon FIB-4 to characterise noninvasively patients with NAFLD? Authors′ reply
    Henry, Linda
    Younossi, Zobair
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (08) : 922 - 923
  • [2] Non-invasive detection of NASH and significant fibrosis in NAFLD patients with low FIB-4
    Liebig, Stephanie
    Hohenester, Simon
    Manns, Michael P.
    Bantel, Heike
    JOURNAL OF HEPATOLOGY, 2020, 73 : S403 - S403
  • [3] Non-Invasive Detection of Fibrotic NASH in NAFLD Patients with Low or Intermediate FIB-4
    John, Katharina
    Franck, Martin
    Al Aoua, Sherin
    Rau, Monika
    Huber, Yvonne
    Schattenberg, Joern M.
    Geier, Andreas
    Bahr, Matthias J.
    Wedemeyer, Heiner
    Schulze-Osthoff, Klaus
    Bantel, Heike
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (15)
  • [4] FIB-4: more accurate non-invasive assessment for advanced fibrosis among patients with NAFLD
    Uy, D.
    Cua, I. H.
    Bocobo, J.
    Cervantes, J.
    Edano, J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 158 - 158
  • [5] FIB-4 index to rule-out advanced liver fibrosis in NAFLD patients
    Mallet, Vincent
    Parlati, Lucia
    Vallet-Pichard, Anais
    Terris, Benoit
    Tsochatzis, Emmanuel
    Sogni, Philippe
    Pol, Stanislas
    PRESSE MEDICALE, 2019, 48 (12): : 1484 - 1488
  • [6] Diagnostic accuracy of non-invasive Methods (NFS Score and FIB-4) for detecting advanced fibrosis: Avalidation study of NFS score and FIB-4 in a cohort of South Indian patients with NAFLD
    Panackel, Charles
    Jacob, Mathew
    Francis, Joe
    Raja, Kaiser
    Sakpal, Mallikarjun
    Ganjoo, Naveen
    Asthana, Sonal
    Lochan, Rajiv
    Saif, Rehan
    Reddy, Jayanth
    Siyad, Ismail
    Ramesh, Ganesh
    Sandhyav, Rommel
    Noushif, M.
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E768 - E768
  • [7] NAFLD FIBROSIS SCORE OUTPERFORMS FIB-4 AND APRI IN PREDICTING ADVANCED FIBROSIS IN NON-NAFLD ETIOLOGIES OF LIVER DISEASE
    Baldwin, Nicholas
    Ravi, Sujan
    Boudreaux, Jordan
    Lin, Chee Paul
    Orandi, Babak
    Gray, Meagan
    GASTROENTEROLOGY, 2020, 158 (06) : S1384 - S1385
  • [8] The combination of the ELF and FIB-4 scores have high predictive performance for significant fibrosis in patients with NAFLD
    Younossi, Zobair
    Felix, Sean
    Jeffers, Thomas
    Younossi, Elena
    Nader, Fatema
    Racila, Andrei
    Lam, Brian
    Stepanova, Maria
    JOURNAL OF HEPATOLOGY, 2022, 77 : S420 - S420
  • [9] Impact of Implementing a "FIB-4 First" Strategy on a Pathway for Patients With NAFLD Referred From Primary Care
    Davyduke, Tracy
    Tandon, Puneeta
    Al-Karaghouli, Mustafa
    Abraldes, Juan G.
    Ma, Mang M.
    HEPATOLOGY COMMUNICATIONS, 2019, 3 (10) : 1322 - 1333
  • [10] Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population
    Zambrano-Huailla, Rommel
    Guedes, Laura
    Stefano, Jose Tadeu
    de Souza, Arthur A. Arrais
    Marciano, Sebastian
    Yvamoto, Erika
    Michalczuk, Matheus Truccolo
    Vanni, Denise Siqueira
    Rodriguez, Hernan
    Carrilho, Flair Jose
    Alvares-da-Silva, Mario Reis
    Gadano, Adrian
    Arrese, Marco
    Miranda, Adelina Lozano
    Oliveira, Claudia P.
    ANNALS OF HEPATOLOGY, 2020, 19 (06) : 622 - 626
12345